Prostate Cancer Development Is Not Affected by Statin Use in Patients with Elevated PSA Levels

by Dennie Meijer, R. Jeroen A. van Moorselaar, André N. Vis, Irene V. Bijnsdorp
Published 2019-07-01

Nuclear Imaging for Bone Metastases in Prostate Cancer: The Emergence of Modern Techniques Using Novel Radiotracers

by Wietske I. Luining, Dennie Meijer, Max R. Dahele, André N. Vis, Daniela E. Oprea-Lager
Published 2021-01-01

External Validation of Two Nomograms Developed for 68Ga-PSMA-11 Applied to the Prostate-specific Membrane Antigen Tracer 18F-DCFPyl: Is Prediction of the Optimal Timing of Salvage...

by Henk B. Luiting, Sebastiaan Remmers, Dennie Meijer, André N. Vis, Maarten Donswijk, Daniela E. Oprea-Lager, Louise Emmett, Isabel Rauscher, Henk G. Van der Poel, Monique J. Roobol, Pim J. van Leeuwen
Published 2021-06-01

Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer.

by Dennie Meijer, Bernard H E Jansen, Maurits Wondergem, Yves J L Bodar, Sandra Srbljin, Annelies E Vellekoop, Bram Keizer, Friso M van der Zant, Otto S Hoekstra, Jakko A Nieuwenhuijzen, Max Dahele, André N Vis, Daniela E Oprea-Lager
Published 2020-01-01

Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial

by Bastiaan M. Privé, Marcel J. R. Janssen, Inge M. van Oort, Constantijn H. J. Muselaers, Marianne A. Jonker, Michel de Groot, Niven Mehra, J. Fred Verzijlbergen, Tom W. J. Scheenen, Patrik Zámecnik, Jelle O. Barentsz, Martin Gotthardt, Walter Noordzij, Wouter V. Vogel, Andries M. Bergman, Henk G. van der Poel, André N. Vis, Daniela E. Oprea-Lager, Winald R. Gerritsen, J. Alfred Witjes, James Nagarajah
Published 2020-09-01